Seres Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Seres Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1672% to $126,325,000. The net income raised on -$113,724,000 and profit margin reached -90%. Total operating expenses were $233,604,000.
Profit Margin
| 2014 | 0 | -16.70M | |
|---|---|---|---|
| 2015 | 0 | -54.78M | |
| 2016 | 21.76M | -91.57M | -420.74% |
| 2017 | 32.1M | -89.38M | -278.44% |
| 2018 | 28.26M | -98.94M | -350.03% |
| 2019 | 34.50M | -64.24M | -186.19% |
| 2020 | 33.21M | -86.45M | -260.29% |
| 2021 | 144.92M | -61.49M | -42.43% |
| 2022 | 7.12M | -253.82M | -3560.94% |
| 2023 | 126.32M | -113.72M | -90.02% |
MCRB Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 126.32M | 7.12M | 144.92M | 33.21M | 34.50M | 28.26M | 32.1M | 21.76M | 0 | 0 |
Cost of revenue | 704K | 1.00M | 1.73M | 90.57M | 80.14M | 0 | 89.45M | 0 | 728K | 10.71M |
Gross profit | 125.62M | 6.12M | 143.19M | -57.35M | -45.63M | 28.26M | -57.35M | 21.76M | -728K | -10.71M |
Operating exp. | ||||||||||
Research and development | 145.86M | 172.92M | 141.89M | 90.57M | 80.14M | 95.95M | 89.45M | 81.98M | 38.09M | 10.71M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 233.60M | 253.61M | 209.42M | 121.34M | 104.88M | 128.55M | 123.49M | 114.60M | 54.85M | 15.08M |
Operating income | -107.98M | -246.49M | -64.49M | -88.13M | -71.87M | -100.28M | -91.39M | -92.83M | -54.85M | -15.08M |
Other income (expenses), net | -5.74M | -3.66M | -1.08M | -997K | 1.59M | 170K | 2.01M | 1.26M | 76K | -1.62M |
Income before tax | -113.72M | -250.15M | -65.57M | -89.12M | -70.27M | -98.94M | -89.38M | -91.57M | -54.78M | -16.70M |
Income tax expense | 0 | 3.66M | -4.08M | -2.67M | -6.03M | 1.34M | -1.59M | 2.22M | -804K | 1.62M |
Net income | -113.72M | -253.82M | -61.49M | -86.45M | -64.24M | -98.94M | -89.38M | -91.57M | -54.78M | -16.70M |
Earnings per share | ||||||||||
Basic EPS | -0.89 | -2.35 | -0.67 | -1.08 | -1.13 | -2.43 | -2.21 | -2.3 | -2.33 | -0.56 |
Diluted EPS | -0.89 | -2.35 | -0.67 | -1.08 | -1.13 | -2.43 | -2.21 | -2.3 | -2.33 | -0.56 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |